Preventing progression to first-episode psychosis in early initial prodromal states

British Journal of Psychiatry

Volumn 200, Issue 1, 2012, Pages 22-29

  Bechdolf, Andreas ^a,b   Wagner, M ^c   Ruhrmann, S ^a   Harrigan, S ^b   Putzfeld, V ^a   Pukrop, R ^a   Brockhaus Dumke, A ^a   Berning, J ^c   Janssen, B ^d   Decker, P ^e   Bottlender, R ^e   Maurer, K ^f   Moller H J ^e   Gaebel, W ^d   Hafner H ^f   Maier, W ^c   Klosterkotter J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF BONN   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COGNITIVE DEFECT; COGNITIVE THERAPY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INTEGRATED PSYCHOLOGICAL INTERVENTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PROSPECTIVE STUDY; PSYCHOEDUCATION; PSYCHOSIS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AMBULATORY CARE; COGNITIVE THERAPY; COUNSELING; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FAMILY HEALTH; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PATIENT EDUCATION AS TOPIC; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84855520862     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.109.066357     Document Type: Article

References (46)

1. Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, et al. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 2003; 289: 2534-44. (Pubitemid 37430155)
2. Peters AL, Davidson MB, Schriger DL, Hasselbald V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis research group on the diagnosis of diabetes using glycosylated hemoglybin levels. JAMA 1996; 276: 1246-52. (Pubitemid 26337708)
3. Adams EK, Breen N, Joski PJ. Impact of the National Breast and Cervical Detection Program on mammography and pap test utilization among white, Hispanic, and African American women: 1996-2000. Cancer 2007; 109: 348-58. (Pubitemid 46106219)
4. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 2004; 67: 131-42. (Pubitemid 38251443)
5. Ruhrmann S, Schultze-Lutter F, Salokangas RK, Heinimaa M, Linszen D, Dingemans P, et al. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 2010; 67: 241-51.
6. Cannon TD, Cadenhead K, Conblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multi-site longitudinal study in North America. Arch Gen Psychiatry 2008; 65: 28-37.
7. McGorry PD, Yung AR, Phillips LJ. The 'close-in' or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull 2003; 29: 771-90. (Pubitemid 38181956)
8. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, et al. Can first episode psychosis be delayed or prevented? A randomized controlled trial of interventions during the prepsychotic phase of schizophrenia and related psychosis. Arch Gen Psychiatry 2002; 59: 921-8.
9. Morrison AP, French P, Walford L, Lewis SW, Kilcommons A, Green J, et al. Cognitive therapy for the prevention of psychosis in people at ultra-high risk. randomised controlled trial. Br J Psychiatry 2004; 185: 291-7. (Pubitemid 39331330)
10. Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res 2011; 125: 54-61.
11. McGlashan TH, Zipursky RB, Perkins D, Addington J, Miller T, Woods SW, et al. A randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psychiatry 2006 163: 790-9. (Pubitemid 44464525)
12. Amminger GP, Schäfer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry 2010; 67: 146-54.
13. Morrison AP, French P, Parker S, Roberts M, Stevens H, Bentall RP, et al. Three year follow-up of a randomised controlled trial of cognitive therapy for the prevention of psychosis in people at ultra-high risk. Schizophr Bull 2007; 33: 682-7. (Pubitemid 47343709)
14. Phillipps LJ, McGorry PD, Yuen HP, Ward J, Donovan K, Kelly D, et al. Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Shizophr Res 2007; 96: 25-33. (Pubitemid 47494628)
15. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158-64. (Pubitemid 32142753)
16. Gross G, Huber G. Psychopathology of basic stages of schizophrenia in view of formal thought disturbances. Psychopathology 1985; 18: 115-25. (Pubitemid 16224271)
17. Bechdolf A, Pukrop R, Köhn D, Tschinkel S, Schultze-Lutter F, Ruhrmann S, et al. Subjective quality of life in subjects at risk for first episode psychosis: a comparison with first episode schizophrenia patients and healthy controls. Schizophr Res 2005; 79: 137-41.
18. Brockhaus-Dumke A, Ruhrmann S, Tendolkar I, Pukrop R, Klosterkötter J. Impaired mismatch negativity (MMN) generation in prodromal and schizophrenia patients. Schizophr Res 2005; 73: 297-310. (Pubitemid 40093893)
19. Pukrop R, Schultze-Lutter F, Ruhrmann S, Brockhaus-Dumke A, Tendolkar I, Bechdolf A, et al. Neurocognitive indicators for a transition to psychosis: comparison of subjects at risk who transited to psychosis and who did not transit. Schizophrenia Res 2007; 92: 116-25. (Pubitemid 46561233)
20. Bechdolf A, Ruhrmann S, Wagner M, Kühn KU, Janssen B, Bottlender R, et al. Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment. Br J Psychiatry 2005; 187 (suppl 48): s45-8. (Pubitemid 41139665)
21. Häfner H, Maurer K, Ruhrmann S, Bechdolf A, Klosterkötter J, Wagner M, et al. Are early detection and secondary prevention feasible? Facts and visions. Eur Arch Psychiatry Clin Neurosci 2004; 254: 117-28. (Pubitemid 39304479)
22. Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C. Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev 2004; 4: CD000524.
23. Pilling S, Bebbington P, Kuipers E, Garety P, Geddes J, Orbach G, et al. Psychological treatment in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy. Psychol Med 2002; 32: 763-82. (Pubitemid 34823330)
24. Penn DL, Waldheter EJ, Perkins DO, Mueser KT, Lieberman JA. Psychosocial treatment for first-episode psychosis. A research update. Am J Psychiatry 2005; 162: 220-32.
25. Work Group on Panic Disorder, American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry 1998; 155 (suppl 5): 1-34.
26. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157 (suppl 4): 1-45.
27. Haefner H, Bechdolf A, Klosterkötter J, Maurer K. Early Detection and Intervention in Psychosis. A Practise Handbook. Schattauer, 2011.
28. Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analysis. Am J Psychiatry 2002; 159: 1080-92. (Pubitemid 34743246)
29. Geddes JR, Lawrie SM. Obstetric complications and schizophrenia: a meta-analysis. Br J Psychiatry 1995; 167: 786-93. (Pubitemid 26197797)
30. Nuechterlein KH, Dawson ME. A heuristic vulnerability/stress model of schizophrenic episodes. Schizophr Bull 1984; 10: 300-12.
31. Larsen TK, Bechdolf A, Birchwood M. The concept of schizophrenia and phase specific treatment. Psychological treatment in pre-psychosis and nonresponders. J Am Acad Psychoanal Dyn Psychiatry 2003; 31: 209-28. (Pubitemid 36459216)
32. Chadwick PDJ, Birchwood M, Trower P. Cognitive Therapy for Delusions, Voices and Paranoia. John Wiley & Sons, 1996.
33. Fowler D, Garety P, Kuipers E. Cognitive Behaviour Therapy for People with Psychosis. John Wiley & Sons, 1995.
34. Kingdon D, Turkington D. Cognitive-Behavioural Therapy for Schizophrenia. Lawrence Erlbaum, 1995.
35. Beck AT. Cognitive Therapy and the Emotional Disorders. International University Press, 1976.
36. Bechdolf A, Puetzfeld V, Gross S, Guettgemanns J. Cognitive Behavioural Therapy in People at Risk of Psychosis. Huber, 2010.
37. Bechdolf A, Veith V, Klosterkötter J. Group intervention for people at high risk of developing psychosis. In Working with People at Ultra-high Risk of Developing Psychosis (eds J Addington, SH Francey, AP Morrison): 169-81. John Wiley & Sons, 2006.
38. Bechdolf A, Phillips LJ, Francey S, Leicester S, Morrison AP, Veith V, et al. Recent approaches to psychological interventions for people at risk of psychosis. European Arch Psychiatry Clin Neuroscience 2006: 256: 159-73.
39. Bechdolf A, Veith V, Berning J, Stamm E, Janssen B, Wagner M, et al. Cognitive-behavioural therapy in the pre-psychotic phase. An exploratory study. Psychiatr Res 2005; 136: 251-5. (Pubitemid 41765223)
40. Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, et al. IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 1992; 6: 209-23.
41. Lewis SW, Murray RM. Obstetric complications, neurodevelopment deviance and risk of schizophrenia. J Psychiatr Res 1987; 21: 413-21. (Pubitemid 18010253)
42. Kay SR, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 507-18.
43. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) (DSM-IV). APA, 1994.
44. Cicchetti DV, Sparrow SA. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behaviour. Am J Ment Defic 1981; 86: 127-37. (Pubitemid 11006962)
45. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. BMJ 1995; 310: 452-4.
46. Tarrier N, Wykes T. Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale? Behav Res Ther 2004; 42: 1377-401. (Pubitemid 39410355)